Skip to main content
logo
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
5.19
-0.02 (-0.38%)
Aug 26, 2026, 12:30 PM EDT - Market open

Oramed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2161139893471544
Market Cap Growth
146.17%16.28%4.69%-80.20%-13.48%-15.00%
Enterprise Value
144-21-46-9311444
Last Close Price
5.212.662.262.1511.2113.31

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
1.261.79-16.87--
Forward PE
-14.4014.4014.4014.4014.40
PS Ratio
-56.72-69.54174.08200.54
PB Ratio
0.680.570.670.573.113.26
P/TBV Ratio
0.680.570.670.573.103.27

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----115.15163.83

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.320.010.00
Net Debt / Equity Ratio
-0.23-0.67-0.97-0.69-1.02-0.90
Net Debt / EBITDA Ratio
4.988.9211.257.213.824.05
Net Debt / FCF Ratio
13.7614.5816.7910.645.454.48
Asset Turnover
-0.01-0.010.02-
Quick Ratio
4.856.6224.973.0527.1019.85
Current Ratio
4.986.9825.193.0627.3420.08
Return on Equity (ROE)
74.24%37.10%-12.39%3.24%-23.77%-
Return on Assets (ROA)
-3.42%-4.88%-4.25%-5.16%-14.95%-
Return on Invested Capital (ROIC)
-5.23%-32.68%-45.44%-64.63%-473.17%-169.08%
Return on Capital Employed (ROCE)
-4.00%-7.10%-8.50%-9.40%-26.00%-21.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
80.32%56.46%-19.54%5.93%-7.77%-6.44%
FCF Yield
-2.41%-8.07%-8.64%-11.32%-6.04%-6.14%
Buyback Yield / Dilution
-2.31%-3.84%-0.70%-4.02%-5.08%-30.36%
SEC Filings: 10-K · 10-Q